Who Owns Pro Medicus Company?

Pro Medicus Bundle

Get Full Bundle:

	5 FORCES	$15	$10
	BCG	$15	$10
	CANVAS	$15	$10
	4P's MIX	$15	$10
	PESTLE	$15	$10
	SWOT	$15	$10

TOTAL:

ADD TO CART

Who Owns Pro Medicus?

Understanding Pro Medicus' ownership is key to its strategy and influence. The co-founders' significant share sale in late 2024 highlights this importance.

Founded in 1983, Pro Medicus is a global leader in healthcare imaging solutions, with its Visage 7 platform central to its success. As of July 2025, its market capitalization stands at roughly A$34 billion.

Who holds the keys to this influential healthcare technology company?

Pro Medicus Limited was co-founded in 1983 by Dr. Sam Hupert and Anthony Hall. Their shared passion for wine led to a collaboration that would revolutionize medical technology. Dr. Hupert, a medical doctor, saw the potential of computers in healthcare, while Mr. Hall, a scientist, provided the technical expertise to build the company's core software.

Founding Vision The founders aimed to streamline medical practice operations. Their initial focus was on clinical records, building management, and scheduling.	Early Technological Adoption They introduced secure email and digital systems for Australian medical professionals. The company secured one of Australia's first internet domain names in the early 1990s.	Initial Investment Dr. Hupert and Anthony Hall provided all the initial finance and equity. This early commitment laid the groundwork for the company's future growth.
Founder Roles Dr. Hupert transitioned from general practice to lead the company's management. Anthony Hall served as the principal architect and developer of the core software systems.	Sustained Ownership The founders maintained significant ownership stakes throughout the company's expansion. Even after the ASX listing in October 2000, they held substantial equity.	Ownership Structure Post-Listing As of October 2023, both Dr. Hupert and Anthony Hall each retained approximately 25% ownership. This indicates a strong founder influence on Pro Medicus ownership.

The early years of Pro Medicus were characterized by the founders' direct involvement and significant equity. Dr. Sam Hupert, with his medical background, and Anthony Hall, with his technical expertise, were instrumental in shaping the company's direction and its Mission, Vision & Core Values of Pro Medicus. Their initial investment and ongoing commitment ensured that their vision for integrating technology into medicine was realized, leading to substantial Pro Medicus stock ownership for both co-founders even after the company's public offering.

Pro Medicus Ownership History

The Pro Medicus company structure has been largely defined by its founders' enduring presence. Their substantial stakes reflect a long-term commitment to the business.

• Co-founded in 1983 by Dr. Sam Hupert and Anthony Hall.
• Initial focus on streamlining medical practice operations.
• Early adoption of digital systems and internet technology.
• Founders maintained significant ownership stakes, reflecting their commitment to Pro Medicus ownership.
• As of October 2023, each founder held approximately 25% of the company's shares.

Pro Medicus SWOT Analysis

• Complete SWOT Breakdown
• Fully Customizable
• Editable in Excel & Word
• Professional Formatting
• Investor-Ready Format

GET TEMPLATE ➔

Pro Medicus Limited (ASX: PME) has seen a significant evolution in its ownership since its listing in October 2000. The acquisition of Visage Imaging in 2009 was a key turning point, reshaping the company into a global player in medical imaging solutions and influencing its shareholder base.

The ownership structure of Pro Medicus is largely dominated by its founders, highlighting a strong commitment to the company's strategic direction. As of July 2025, individual insiders, primarily co-founders Dr. Sam Hupert and Anthony Hall, collectively hold approximately 46% of the company's shares. Dr. Hupert is the largest single shareholder with 23%, and Mr. Hall holds another 23%. This substantial insider ownership suggests a deep alignment of interests with the company's long-term vision. The top four shareholders combined control a majority stake of 51%, indicating a concentrated ownership among key individuals. Institutional investors also play a notable role, with The Vanguard Group, Inc. holding between 2.8% and 2.9% of the stock in early to mid-2025. Other significant institutional holders include BlackRock, Inc., Franklin Resources, Inc., and State Street Global Advisors, Inc. The general public, representing individual investors, accounts for 37% of the Pro Medicus stock ownership. This breakdown of Pro Medicus shareholders demonstrates a blend of founder control and growing institutional support, which is often viewed positively by the market.

Pro Medicus Shareholding Structure

Understanding Pro Medicus company ownership details is crucial for investors. The shareholding structure shows a strong founder influence and increasing institutional backing.

• Pro Medicus ownership is primarily held by individual insiders, with founders owning a significant stake.
• Institutional investors like Vanguard and BlackRock are increasing their holdings.
• The general public holds a substantial percentage, indicating broad investor interest.
• The concentration of ownership among the top shareholders suggests stability.
• This ownership dynamic is a key factor in the company's strategic decisions and overall market performance. For more insights, you can explore the Marketing Strategy of Pro Medicus.

Pro Medicus PESTLE Analysis

• Covers All 6 PESTLE Categories
• No Research Needed – Save Hours of Work
• Built by Experts, Trusted by Consultants
• Instant Download, Ready to Use
• 100% Editable, Fully Customizable

GET TEMPLATE ➔

The governance of Pro Medicus Limited is overseen by its Board of Directors, which includes key figures instrumental in the company's inception and ongoing development. The board's composition reflects a blend of executive leadership and independent expertise, guiding the company's strategic direction and operational management.

The voting power within Pro Medicus is primarily determined by share ownership, adhering to a one-share-one-vote principle for its ordinary fully paid shares. As of December 2024, the company's co-founders, Dr. Sam Hupert and Anthony Hall, are the largest shareholders, collectively holding approximately 46% of the company's shares. This significant stake ensures their substantial influence over corporate decisions and aligns with the long-term vision for Pro Medicus. There is no publicly available information indicating the existence of dual-class shares or other mechanisms that would grant disproportionate voting rights beyond direct shareholdings, contributing to a straightforward ownership structure. Understanding the Competitors Landscape of Pro Medicus can provide further context on market positioning and strategic alliances.

Pro Medicus Shareholder Overview

The ownership structure of Pro Medicus is largely influenced by its founders, who maintain a significant stake. This concentrated ownership often leads to stable strategic direction.

• Founders hold a combined 46% of shares as of December 2024.
• Voting power follows a one-share-one-vote system.
• No evidence of dual-class shares or special voting rights.
• Board composition includes founders and experienced non-executive directors.

Pro Medicus Business Model Canvas

• Complete 9-Block Business Model Canvas
• Effortlessly Communicate Your Business Strategy
• Investor-Ready BMC Format
• 100% Editable and Customizable
• Clear and Structured Layout

GET TEMPLATE ➔

Pro Medicus has experienced significant shifts in its ownership structure over the last few years, notably with substantial share sales by its co-founders and the implementation of a share buyback program. These events have influenced the company's public float and the distribution of its shares among various investor types.

The co-founders, Sam Hupert and Anthony Hall, have been instrumental in shaping Pro Medicus's ownership landscape. In December 2024, they collectively sold 2 million shares, a transaction valued at A$513.5 million. This move, which represented less than 4% of their individual holdings, was a strategic decision to enhance the company's free float, making its shares more accessible to a broader range of investors. Despite this sale, Hupert and Hall continue to be the largest shareholders, each holding over 24 million shares. Their combined ownership post-sale stands at 46% of the total 104.5 million outstanding shares, underscoring their continued significant stake in the company.

Share Buyback Initiative

Pro Medicus initiated a share repurchase program in April 2025, aiming to buy back up to 10% of its issued shares. This program, managed by Goldman Sachs, is designed to return value to shareholders and is a common strategy when management believes the stock is undervalued.

Institutional Investor Activity

Institutional investors are increasingly prominent in the company's shareholder base, with entities like The Vanguard Group, Inc. holding substantial positions. This trend reflects growing confidence in the company's market position and future prospects.

Financial Performance and Outlook

The company's robust financial performance, including a 29.3% year-on-year revenue increase to A$161.5 million and a 36.5% rise in net profit to A$82.8 million for FY2024, bolsters investor confidence. Pro Medicus maintains a strong balance sheet, being debt-free with A$155.4 million in cash and financial assets as of FY2024.

Strategic Growth and Shareholder Returns

Pro Medicus has articulated plans to invest in internal expansion, explore strategic mergers and acquisitions, and continue its commitment to shareholder returns. Analysts generally maintain a positive outlook, with several raising price targets, suggesting a favorable view of the company's Target Market of Pro Medicus and its growth potential.

Pro Medicus Porter's Five Forces Analysis

• Covers All 5 Competitive Forces in Detail
• Structured for Consultants, Students, and Founders
• 100% Editable in Microsoft Word & Excel
• Instant Digital Download – Use Immediately
• Compatible with Mac & PC – Fully Unlocked

GET TEMPLATE ➔